摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6aR,9R)-N-[(1S,2S,4R,7S)-2-hydroxy-5,8-dioxo-4,7-di(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid | 2207-69-4

中文名称
——
中文别名
——
英文名称
(6aR,9R)-N-[(1S,2S,4R,7S)-2-hydroxy-5,8-dioxo-4,7-di(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
英文别名
——
(6aR,9R)-N-[(1S,2S,4R,7S)-2-hydroxy-5,8-dioxo-4,7-di(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid化学式
CAS
2207-69-4;2706-67-4
化学式
C32H43N5O8S
mdl
——
分子量
657.8
InChiKey
JSSWJSBXBKEBMS-CWNVUFIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.54
  • 重原子数:
    46
  • 可旋转键数:
    4
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    181
  • 氢给体数:
    4
  • 氢受体数:
    9

安全信息

  • 危险等级:
    6.1(b)

文献信息

  • HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS
    申请人:THE UNIVERSITY OF ROCHESTER
    公开号:EP1903873A2
    公开(公告)日:2008-04-02
  • Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
    申请人:West D. Michael
    公开号:US20080070303A1
    公开(公告)日:2008-03-20
    This invention generally relates to methods to differentiate pluripotent stem cells, such as embryonic stem, embryonic germ, or embryo-derived cells, to obtain subpopulations of cells from heterogeneous mixtures of cells wherein the subpopulation of cells possess reduced differentiation potential compared to the original pluripotent stem cells and where the subpopulation is capable of being propagated.
  • METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY
    申请人:West Michael D.
    公开号:US20100184033A1
    公开(公告)日:2010-07-22
    Aspects of the present invention relate to methods to differentiate pluripotent primordial stem cells, such as human embryonic stem (“hES”) cells, human embryonic germ (“hEG”) cells, human embryo-derived (“hED”) cells and human embryonal carcinoma (“hEC”) cells, to obtain subpopulations of cells from heterogeneous mixtures of cells, wherein the subpopulation of cells possess reduced differentiation potential compared to the original pluripotent stem cells and where the subpopulation is capable of being propagated 20 or more population doublings. This invention also provides novel compositions of such subpopulations of cells and methods to propagate and differentiate said cells.
  • [EN] HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS<br/>[FR] COMPOSITIONS A BASE DE VIRUS HERPETIQUE ET PROCEDES D'UTILISATION DANS LES PERIODES PRENATALES ET PERINATALES
    申请人:UNIV ROCHESTER
    公开号:WO2006135602A2
    公开(公告)日:2006-12-21
    [EN] Disclosed are compositions and methods for reducing the severity of a birth defect in a mammal by exposing the mammal (e.g., in utero) to a herpes virus amplicon particle comprising a cis element-flanked transgene and a sequence encoding a transposase. Upon expression, the transposase inserts the transgene into the genome of a cell (e.g., a neuron) within the mammal and the transgene expresses a polypeptide or RNA that compensates for a protein or gene defect that is causally associated with the birth defect.
    [FR] L'invention concerne des compositions et des procédés de réduction de la gravité d'une anomalie à la naissance chez un mammifère consistant à exposer le mammifère (par exemple in utéro) à une particule d'amplicon de virus herpétique contenant un transgène flanqué d'un élément cis et une séquence codant une transposase. Lors de l'expression, la transposase insère le transgène dans le génome d'une cellule (par exemple un neurone) à l'intérieur du mammifère et le transgène exprime un polypeptide ou un ARN qui compense une anomalie protéique ou génique associée par effet de causalité à l'anomalie à la naissance.
  • [EN] METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY<br/>[FR] METHODES ACCELERANT L'ISOLEMENT DE NOUVELLES LIGNEES DE CELLULES A PARTIR DE CELLULES SOUCHES PLURIPOTENTES, ET CELLULES AINSI OBTENUES.
    申请人:ADVANCED CELL TECH INC
    公开号:WO2007062198A1
    公开(公告)日:2007-05-31
    [EN] This invention generally relates to methods to differentiate pluripotent stem cells, such as embryonic stem, embryonic germ, or embryo-derived cells, to obtain subpopulations of cells from heterogeneous mixtures of cells wherein the subpopulation of cells possess reduced differentiation potential compared to the original pluripotent stem cells and where the subpopulation is capable of being propagated.
    [FR] L'invention porte d'une manière générale sur des méthodes de différentiation de cellules souches pluripotentes telles des souches d'embryons, des germes d'embryons ou des cellules dérivant d'embryons, pour obtenir, à partir de mélanges de cellules, des sous-populations de cellules, présentant un potentiel réduit de différenciation par rapport à celui des souches pluripotentes originales, mais capables de se propager.
查看更多